riluzole has been researched along with HIV Coinfection in 2 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Excerpt | Relevance | Reference |
---|---|---|
"Riluzole is able to increase (effective dose from 1 to 1000 nM) the cell-survival of T cells from HIV-1-infected patients and inhibit spontaneous apoptosis." | 1.35 | Enhanced endogenous type I interferon cell-driven survival and inhibition of spontaneous apoptosis by Riluzole. ( Achour, A; Biquard, JM; M'Bika, JP, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Achour, A | 1 |
M'Bika, JP | 1 |
Biquard, JM | 1 |
Cachia, D | 1 |
Izzy, S | 1 |
Ionete, C | 1 |
Salameh, J | 1 |
2 other studies available for riluzole and HIV Coinfection
Article | Year |
---|---|
Enhanced endogenous type I interferon cell-driven survival and inhibition of spontaneous apoptosis by Riluzole.
Topics: Apoptosis; Cell Survival; HIV Infections; Humans; Immunologic Factors; Interferon Type I; Riluzole; | 2009 |
Brachial amyotrophic diplegia in the setting of complete HIV viral load suppression.
Topics: Antiretroviral Therapy, Highly Active; Arm; HIV Infections; Humans; Male; Middle Aged; Muscle Weakne | 2012 |